INSIGHTS

Home 9 All Posts 9 3PL 9 Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug

Rob Beese

• October 10

Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug

e41585_f2125cbf764845538d2820839320a96e~mv2

Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. As manufacturers prepare for launch, they must sort through and choose third-party organizations that can help support their efforts: 3PL organizations, distribution partners, pharmacies, HUB providers, serialization partners, data analytics, and more.

Getting answers to the eleven key questions covered in this webinar will help guide commercial teams in effectively launching specialty products.

Sometimes, answering that question can feel overwhelming to manufacturers. That’s where we can help.

Learning Objectives Covered in the Webinar:

- Identify the types of third-party organizations that can help support your specialty drug launch
- Understand the key considerations and composition of establishing third-party partnerships
- Determine the difference between having greater access or greater control, and how that can impact the commercial success of your launch

Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. That’s where Archbow’s team of market access experts can help. Contact us today to get started.

Watch the webinar archive here.
Read the blog post on this topic here.

For additional insights on this topic, you may also enjoy the following blog posts:

10 Steps to Building an Integrated Pharmaceutical Launch Strategy

Design the best market access ecosystem for your brand

6 Market Access Mistakes Cell and Gene Therapy Companies Make

Understanding Pharmaceutical Market Access Differences in the US and Europe

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in